| BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection (NCT00337701) | Hoffmann-La Roche | 2006-06-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection (NCT00353418) | Hoffmann-La Roche | 2006-06-01 |
| A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer (NCT02560974) | Hoffmann-La Roche | 2006-06-01 |
| A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. (NCT00545051) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. (NCT00327535) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. (NCT01169558) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation (NCT00372229) | Hoffmann-La Roche | 2006-05-01 |
| A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. (NCT00377234) | Hoffmann-La Roche | 2006-05-01 |
| OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. (NCT02005562) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer (NCT01674062) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma (NCT02079519) | Hoffmann-La Roche | 2006-05-01 |
| A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis (NCT00303563) | Hoffmann-La Roche | 2006-04-01 |
| APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin (NCT02850289) | Hoffmann-La Roche | 2006-04-01 |
| A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors. (NCT00400361) | Hoffmann-La Roche | 2006-04-01 |
| A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) (NCT00545363) | Hoffmann-La Roche | 2006-04-01 |
| A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy (NCT02624141) | Hoffmann-La Roche | 2006-04-01 |
| IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients (NCT00294515) | Hoffmann-La Roche | 2006-03-31 |
| A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis (NCT02081183) | Hoffmann-La Roche | 2006-03-01 |
| A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer (NCT00333775) | Hoffmann-La Roche | 2006-03-01 |
| BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. (NCT00326963) | Hoffmann-La Roche | 2006-03-01 |
| A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00556322) | Hoffmann-La Roche | 2006-03-01 |
| BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis (NCT00545909) | Hoffmann-La Roche | 2006-03-01 |
| A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. (NCT00502996) | Hoffmann-La Roche | 2006-02-01 |
| Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (NCT02739594) | Hoffmann-La Roche | 2006-02-01 |
| A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. (NCT00316758) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) (NCT00303485) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. (NCT00700102) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C (NCT00800748) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer (NCT02005549) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422383) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) (NCT02533401) | Hoffmann-La Roche | 2006-02-01 |
| A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer (NCT02716792) | Hoffmann-La Roche | 2006-01-01 |
| A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program (NCT02791269) | Hoffmann-La Roche | 2006-01-01 |
| A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00556712) | Hoffmann-La Roche | 2006-01-01 |
| Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate (NCT00569452) | Hoffmann-La Roche | 2006-01-01 |
| An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B (NCT01787279) | Hoffmann-La Roche | 2006-01-01 |
| A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes. (NCT00368368) | Hoffmann-La Roche | 2006-01-01 |
| A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422942) | Hoffmann-La Roche | 2006-01-01 |
| A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. (NCT01159171) | Hoffmann-La Roche | 2006-01-01 |
| A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia (NCT00129623) | Hoffmann-La Roche | 2005-12-01 |
| A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections (NCT00303589) | Hoffmann-La Roche | 2005-12-01 |
| A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer (NCT02004093) | Hoffmann-La Roche | 2005-12-01 |
| Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. (NCT00337493) | Hoffmann-La Roche | 2005-12-01 |
| A Study of Bitopertin (RO4917838) in Healthy Male Volunteers (NCT01636492) | Hoffmann-La Roche | 2005-11-01 |
| A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin (NCT00266253) | Hoffmann-La Roche | 2005-11-01 |
| A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus (NCT00266240) | Hoffmann-La Roche | 2005-11-01 |
| A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. (NCT01227707) | Hoffmann-La Roche | 2005-11-01 |
| A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy (NCT00316771) | Hoffmann-La Roche | 2005-11-01 |
| A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience (NCT00487188) | Hoffmann-La Roche | 2005-11-01 |
| CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy (NCT02013817) | Hoffmann-La Roche | 2005-10-11 |
| A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (NCT02598063) | Hoffmann-La Roche | 2005-10-01 |
| A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) (NCT02732639) | Hoffmann-La Roche | 2005-10-01 |
| A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02720120) | Hoffmann-La Roche | 2005-10-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. (NCT01519921) | Hoffmann-La Roche | 2005-10-01 |
| A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis (NCT02827266) | Hoffmann-La Roche | 2005-10-01 |
| A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer (NCT00475670) | Hoffmann-La Roche | 2005-10-01 |
| Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients (NCT00121784) | Hoffmann-La Roche | 2005-10-01 |
| A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. (NCT00493155) | Hoffmann-La Roche | 2005-10-01 |
| ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer (NCT01041404) | Hoffmann-La Roche | 2005-09-01 |
| An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies (NCT00720798) | Hoffmann-La Roche | 2005-09-01 |
| A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain (NCT00099177) | Hoffmann-La Roche | 2005-08-01 |
| WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV. (NCT00233883) | Hoffmann-La Roche | 2005-08-01 |
| A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo (NCT00148915) | Hoffmann-La Roche | 2005-08-01 |
| A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis (NCT00721123) | Hoffmann-La Roche | 2005-08-01 |
| A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer (NCT02581423) | Hoffmann-La Roche | 2005-08-01 |
| XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer (NCT00127933) | Hoffmann-La Roche | 2005-08-01 |
| MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma (NCT02486952) | Hoffmann-La Roche | 2005-08-01 |
| Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant (NCT00118742) | Hoffmann-La Roche | 2005-08-01 |
| A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas (NCT01153971) | Hoffmann-La Roche | 2005-07-20 |
| A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. (NCT00377637) | Hoffmann-La Roche | 2005-07-01 |
| A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer (NCT00118755) | Hoffmann-La Roche | 2005-07-01 |
| A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C) (NCT00697203) | Hoffmann-La Roche | 2005-07-01 |
| A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT02774278) | Hoffmann-La Roche | 2005-07-01 |
| Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253 (NCT01237496) | Hoffmann-La Roche | 2005-07-01 |
| A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP) (NCT00770562) | Hoffmann-La Roche | 2005-07-01 |
| A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma (NCT02569996) | Hoffmann-La Roche | 2005-07-01 |
| A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease (NCT00099203) | Hoffmann-La Roche | 2005-07-01 |
| A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer (NCT01214720) | Hoffmann-La Roche | 2005-07-01 |
| A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. (NCT00353262) | Hoffmann-La Roche | 2005-07-01 |
| A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis (NCT00109408) | Hoffmann-La Roche | 2005-07-01 |
| A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. (NCT00503425) | Hoffmann-La Roche | 2005-06-30 |
| CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants (NCT00788567) | Hoffmann-La Roche | 2005-06-01 |
| A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6 (NCT02791256) | Hoffmann-La Roche | 2005-06-01 |
| A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum (NCT01181609) | Hoffmann-La Roche | 2005-06-01 |
| A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum (NCT01131078) | Hoffmann-La Roche | 2005-06-01 |
| A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes (NCT00111670) | Hoffmann-La Roche | 2005-06-01 |
| A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer (NCT00121836) | Hoffmann-La Roche | 2005-06-01 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy (NCT00106522) | Hoffmann-La Roche | 2005-05-01 |
| A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer (NCT02013830) | Hoffmann-La Roche | 2005-05-01 |
| A Study of R547 in Patients With Advanced Solid Tumors. (NCT00400296) | Hoffmann-La Roche | 2005-05-01 |
| A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes (NCT00111631) | Hoffmann-La Roche | 2005-05-01 |
| A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) (NCT02723071) | Hoffmann-La Roche | 2005-05-01 |
| A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum (NCT02582970) | Hoffmann-La Roche | 2005-05-01 |
| GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection (NCT00105079) | Hoffmann-La Roche | 2005-04-01 |
| A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection (NCT02569502) | Hoffmann-La Roche | 2005-04-01 |
| A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00106574) | Hoffmann-La Roche | 2005-04-01 |
| Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus (NCT02761629) | Hoffmann-La Roche | 2005-04-01 |
| Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT) (NCT02762383) | Hoffmann-La Roche | 2005-03-01 |
| A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer (NCT02694718) | Hoffmann-La Roche | 2005-03-01 |
| A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia (NCT00111644) | Hoffmann-La Roche | 2005-03-01 |